Ovoca Gold Aktie

Ovoca Bio Plc is a clinical-stage biopharmaceutical company, which engages in the women's health, clinical development and commercial planning of BP-101, and novel treatment for women with hypoactive sexual desire disorder (HSDD). It operates through the following segments: Bio-pharmaceutical, Investment, and Administrative. The Bio-pharmaceutical segment covers activities that are carried out by IVIX LLC and OVB Australia Pty. The Investment segment represents activities carried out by Silver Star Limited, a subsidiary company located in Bermuda. The Administrative segment consists of the group administration costs. The company was founded on January 15, 1985 and is headquartered in Dublin, Ireland.